Down Syndrome
|
0.320 |
Biomarker
|
disease |
CTD_human |
A number of miRNAs are overexpressed in down syndrome, including miR-155, miR-802, miR- 125b-2, let-7c and miR-99a.
|
29403643 |
2018 |
Down Syndrome
|
0.320 |
AlteredExpression
|
disease |
BEFREE |
Recently, the over expression of chromosome 21-derived microRNAs (miR-99a, let-7c, miR-125b-2, miR-155 and miR-802) in human fetal hippocampus and heart samples from individuals with Down syndrome was observed.
|
24521639 |
2013 |
Down Syndrome
|
0.320 |
Biomarker
|
disease |
BEFREE |
Thus, we propose miR-125b-2 as a positive regulator of megakaryopoiesis and an oncomiR involved in the pathogenesis of trisomy 21-associated megakaryoblastic leukemia.
|
20194440 |
2010 |
Cardiomegaly
|
0.300 |
Therapeutic
|
phenotype |
CTD_human |
A carvedilol-responsive microRNA, miR-125b-5p protects the heart from acute myocardial infarction by repressing pro-apoptotic bak1 and klf13 in cardiomyocytes.
|
29122578 |
2018 |
Myocardial Infarction
|
0.300 |
Therapeutic
|
disease |
CTD_human |
A carvedilol-responsive microRNA, miR-125b-5p protects the heart from acute myocardial infarction by repressing pro-apoptotic bak1 and klf13 in cardiomyocytes.
|
29122578 |
2018 |
Ventricular Dysfunction, Left
|
0.300 |
Therapeutic
|
phenotype |
CTD_human |
A carvedilol-responsive microRNA, miR-125b-5p protects the heart from acute myocardial infarction by repressing pro-apoptotic bak1 and klf13 in cardiomyocytes.
|
29122578 |
2018 |
Down Syndrome, Partial Trisomy 21
|
0.300 |
Biomarker
|
disease |
CTD_human |
Down syndrome and microRNAs.
|
29403643 |
2018 |
Trisomy 21, Meiotic Nondisjunction
|
0.300 |
Biomarker
|
disease |
CTD_human |
Down syndrome and microRNAs.
|
29403643 |
2018 |
Endomyocardial Fibrosis
|
0.300 |
Therapeutic
|
phenotype |
CTD_human |
A carvedilol-responsive microRNA, miR-125b-5p protects the heart from acute myocardial infarction by repressing pro-apoptotic bak1 and klf13 in cardiomyocytes.
|
29122578 |
2018 |
Trisomy 21, Mitotic Nondisjunction
|
0.300 |
Biomarker
|
disease |
CTD_human |
Down syndrome and microRNAs.
|
29403643 |
2018 |
Cardiac Hypertrophy
|
0.300 |
Therapeutic
|
phenotype |
CTD_human |
A carvedilol-responsive microRNA, miR-125b-5p protects the heart from acute myocardial infarction by repressing pro-apoptotic bak1 and klf13 in cardiomyocytes.
|
29122578 |
2018 |
Hepatitis B
|
0.300 |
Biomarker
|
disease |
CTD_human |
"Serum microRNA signatures as ""liquid biopsies"" for interrogating hepatotoxic mechanisms and liver pathogenesis in human."
|
28545106 |
2017 |
Hepatitis, Toxic
|
0.300 |
Biomarker
|
disease |
CTD_human |
"Serum microRNA signatures as ""liquid biopsies"" for interrogating hepatotoxic mechanisms and liver pathogenesis in human."
|
28545106 |
2017 |
Drug-Induced Liver Disease
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
"Serum microRNA signatures as ""liquid biopsies"" for interrogating hepatotoxic mechanisms and liver pathogenesis in human."
|
28545106 |
2017 |
Hepatitis, Drug-Induced
|
0.300 |
Biomarker
|
disease |
CTD_human |
"Serum microRNA signatures as ""liquid biopsies"" for interrogating hepatotoxic mechanisms and liver pathogenesis in human."
|
28545106 |
2017 |
Drug-Induced Acute Liver Injury
|
0.300 |
Biomarker
|
disease |
CTD_human |
"Serum microRNA signatures as ""liquid biopsies"" for interrogating hepatotoxic mechanisms and liver pathogenesis in human."
|
28545106 |
2017 |
Chemical and Drug Induced Liver Injury
|
0.300 |
Biomarker
|
disease |
CTD_human |
"Serum microRNA signatures as ""liquid biopsies"" for interrogating hepatotoxic mechanisms and liver pathogenesis in human."
|
28545106 |
2017 |
Chemically-Induced Liver Toxicity
|
0.300 |
Biomarker
|
disease |
CTD_human |
"Serum microRNA signatures as ""liquid biopsies"" for interrogating hepatotoxic mechanisms and liver pathogenesis in human."
|
28545106 |
2017 |
Non-Small Cell Lung Carcinoma
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
To investigate the associations between the functional single nucleotide polymorphisms (SNPs) in the miR-125 family and the survival of non-small cell lung cancer (NSCLC) patients, we systematically selected six functional SNPs located in three pre-miRNAs (miR-125a, miR-125b-1, miR-125b-2).
|
30843663 |
2019 |
Male infertility
|
0.010 |
AlteredExpression
|
phenotype |
BEFREE |
The study indicated that miR-125b-2 had a positive influence on the reproductive performance of animals by regulating the expression of the PAP gene, and could be a potential drugs and diagnostic target for male infertility.
|
30609807 |
2019 |
Anorectal Malformations
|
0.010 |
AlteredExpression
|
group |
BEFREE |
In conclusion, the results suggested that the differential expression of miR‑125b‑2‑3p, miR‑92a‑2‑5p and miR‑99a‑5p during key time-points of anorectal formation in rats may have functions in the pathogenesis of ARM.
|
30106085 |
2018 |
Acute lymphocytic leukemia
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
High expression of miR-125b-2 and SNORD116 noncoding RNA clusters characterize ERG-related B cell precursor acute lymphoblastic leukemia.
|
28415578 |
2017 |
Carcinogenesis
|
0.010 |
Biomarker
|
phenotype |
BEFREE |
Thus, hsa-miR-26b-5p, hsa-miR-221-3p and hsa-miR-125b-2-3p may be involved in SCO tumorigenesis.
|
28477009 |
2017 |
Ischemic stroke
|
0.010 |
Biomarker
|
disease |
BEFREE |
Therefore, we explored the potential predictive value of plasma exosomal miR-422a and miR-125b-2-3p in different IS phases (acute and subacute phases).
|
28982331 |
2017 |
Precursor Cell Lymphoblastic Leukemia Lymphoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
High expression of miR-125b-2 and SNORD116 noncoding RNA clusters characterize ERG-related B cell precursor acute lymphoblastic leukemia.
|
28415578 |
2017 |